Juergen A. Martens
Plus aucun poste en cours
Historique de carrière de Juergen A. Martens
Anciens postes connus de Juergen A. Martens
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NEOS THERAPEUTICS, INC. | Directeur des opérations | 31/05/2016 | 30/06/2017 |
| Directeur Technique/Scientifique/R&D | 31/05/2016 | 30/06/2017 | |
| MANNKIND CORPORATION | Directeur des opérations | 09/01/2015 | 18/03/2016 |
| Directeur Technique/Scientifique/R&D | 01/09/2005 | 01/01/2015 | |
| NEKTAR THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/01/2000 | 01/08/2005 |
Formation de Juergen A. Martens
| Philipps University of Marburg | Doctorate Degree |
| Mannheim Technical College | Undergraduate Degree |
| University of Pennsylvania | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Allemagne | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Operating Officer | 2 |
| Graduate Degree | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| Entreprise privées | 1 |
|---|---|
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
- Bourse
- Insiders
- Juergen A. Martens
- Expérience
